top of page

Join Our Diabetes Community

We're researching and developing non-contact, optical diabetes screening and monitoring devices. Find out more, discover how you can help and join our community.

With your help, we can make the lives of millions of people better!

Join the conversation

  • Facebook
  • Twitter
  • LinkedIn

Why should you join our community?

Occuity has a mission to improve the screening and monitoring of some of humanity's greatest health challenges - starting with diabetes.

If you believe in our vision, please sign up as only if we have your support are we ever going to be successful in creating a better way to screen and monitor for this disease. 

Benefits & Opportunities

  • Be Informed - Stay up-to-date with our progress

  • Inform Us - Take part in surveys and groups - ultimately helping our R&D team make crucial decisions on design, function, name, look, feel and more.

  • Take Part - Help us with crucial clinical trials (remember our device will be non-contact and pain-free!) and tell us your story of living with diabetes - using the form below.

  • Reviews - Help us spread the word by being amongst the first to use the Occuity Glucose Monitor

Thank you for all your support.


Join Our
Diabetes Community


  • How does a pachymeter work?
    The Occuity PM1 pachymeter uses an optical technique which means it is completely non -contacting, unlike existing invasive ultrasound pachymeters, which have to directly contact a patient's eye. The measurement principle is a called a confocal scan – a tightly focussed beam of invisible light is scanned through the cornea and the reflections are detected and analysed to determine the thickness of the cornea.
  • What price-range do you anticipate the device will be in?
    We intend that the price will be competitive with the existing ultrasound meters. The PM1 will have many significant advantages, such as the fact it is non-contacting, provides a better customer experience, uses no consumables and is safer and easier to operate. The PM1 can be purchased through distributors in each geography.
  • What practice environments do you anticipate Occuity PM1 pachymeter will benefit the most?
    Most practice environments would benefit from a pachymeter, primarily in order to better understand the patient’s risk of glaucoma. The Corneal Centre Thickness (CCT), can aid the validity and accuracy of the IOP (intra ocular pressure) measured by the tonometer. Knowing the CCT will allow clinicians to understand if their tonometer is actually under or over estimating the IOP. Many clinicians also make the mistake of not knowing what their tonometer assumes corneal thickness to be. Most non-contact tonometers assume a corneal thickness of 550 microns, whereas the Goldmann assumes a thickness of 520 microns. If a practice is involved in Glaucoma shared care, for example, they should measure CCT and provide this with their reports, along with IOP and sometimes ‘corrected’ IOP. Patients with thinner corneas are at a higher risk of glaucoma as well, so understanding the risk factors is important. However, there are also other circumstances where CCT may be useful, such as detection of Fuch’s endothelial dystrophy in post cataract patients, detection or progression of KCC (Keratoconus) or other corneal ectasia’s.
  • It takes just a few seconds – is this for one reading or multiple? How many readings are required per eye?
    The PM1 pachymeter, once alligned automatically captures over 200 scans each second, before immediately displaying the average of these measurements along with the standard deviation (precision) figure.
Indigo Colour.png

Q&A with
CEO Dan Daly

The Occuity
Glucose Monitor

We're working on the research and development of a revolutionary new way of monitoring blood glucose levels. The Occuity Glucose Monitor will make it easier for people to check their glucose levels through a simple scan of the eye, removing the need for them to endure painful, complicated and invasive finger-prick blood tests. 

The handheld monitor will work by measuring subtle changes within the anterior chamber of the eye in just a few seconds before analysing the results instantly to determine blood glucose levels. 

As this technique will be non-invasive, simple to use and require no other disposable items, users will be able to perform tests as regularly as they need to, with no additional costs.

NB. The Occuity Glucose Monitor is still in the research and development phase.

  • No pain

  • No risk of infection

  • None of the side effects associated with finger-prick tests

Easy to OPerate.png
  • Simple Compact Handheld Design

  • Quick Operation

  • Cost Effective

  • No consumables

  • State of the Art Optical Technology

  • Accurate Measurement

  • Unlimited Scans


Diabetes Screening

With the scale of diabetes a growing problem, early intervention is crucial as the longer diabetes goes undetected, the more damaging its effects can be. However for diabetes to be detected effectively, a viable, simple to use device that can be used repeatedly in a non-clinical setting is required – namely the Occuity Diabetes Screening device.

The need for early detection and Diabetes screening

We are working on the development of a diabetes screening device that will be capable of being used by both clinicians and non-clinicians. It will be available as a service in opticians, pharmacies and care homes or even for personal use by individuals themselves in entirely non-clinical settings.


Building on our world-leading optical technology, our screening device will have fluorescence capability. This new technology provides the capability to detect disease markers in the eye such as AGE’s (Advanced Glycation End products) in the case of diabetes and pre-diabetes or Amyloid Plaques in respect of Alzheimer’s disease.



Let us know your thoughts

If you're affected by diabetes or know someone who is, and want to leave us a message about your experiences with existing glucose monitoring methods and your views on our development of non-contact optical glucose monitor, we'd love to hear from you.

bottom of page